Closing the Amgen One Myeloma stream, Professor Keith Stewart from the Mayo Clinic in Phoenix, Arizona weighed in on what he thinks will be the future of multiple myeloma (MM) treatment. He kicked off the discussion by focussing on the newly-diagnosed patient. Staging disease with genomics and advanced imaging “I think this is a question ...
Professor Keith Stewart’s top 10 predictions for the future of myeloma management
Sponsored by Amgen Australia Pty Ltd
4 Jun 2019